Literature DB >> 8025737

Altered alveolar surfactant is an early marker of acute lung injury in septic adult sheep.

J F Lewis1, R Veldhuizen, F Possmayer, W Sibbald, J Whitsett, R Qanbar, L McCaig.   

Abstract

The purpose of this study was to characterize changes in the endogenous surfactant system in adult sheep rendered septic via cecal ligation and perforation (CLP). Forty-eight hours after CLP, septic animals had significant increases in mean pulmonary artery pressure (PAP) (p < 0.01), cardiac index (CI) (p < 0.01), and arterial lactate (p < 0.05) values compared with their respective baseline values, while the same measurements in a sham-operated control group did not change significantly. The changes in the septic group were associated with significantly lower PaO2 (p < 0.05) and alveolar to arterial (A-a) oxygen gradient values (p < 0.01) at 48 h compared with baseline measurements. No changes in oxygenation occurred within the sham-operated group. Surfactant phospholipid (PL) composition and surface activity measurements of isolated alveolar surfactant aggregate forms were similar for the two groups at 48 h. However, the ratio of poorly functioning small aggregate forms (SA) to superior functioning large aggregates (LA) was significantly increased in the septic versus the sham-operated animals (p < 0.01). This was associated with significantly decreased surfactant protein A (SP-A), B (SP-B), and C (SP-C) levels in septic versus sham-operated animals (p < 0.05). We conclude that sepsis-associated lung injury resulted in altered alveolar surfactant aggregate forms. These changes, together with altered surfactant protein levels, may represent a very sensitive marker of acute lung injury in high-risk patients. Furthermore, these findings suggest that exogenous surfactant given at an early stage of lung injury may mitigate progressive lung dysfunction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8025737     DOI: 10.1164/ajrccm.150.1.8025737

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  8 in total

1.  Regional pulmonary inflammation in an endotoxemic ovine acute lung injury model.

Authors:  A Fernandez-Bustamante; R B Easley; M Fuld; D Mulreany; D Chon; J F Lewis; B A Simon
Journal:  Respir Physiol Neurobiol       Date:  2012-06-21       Impact factor: 1.931

2.  Temporal sequence of pulmonary and systemic inflammatory responses to graded polymicrobial peritonitis in mice.

Authors:  C Stamme; D S Bundschuh; T Hartung; U Gebert; L Wollin; R Nüsing; A Wendel; S Uhlig
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 3.  Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques.

Authors:  Chrysi Keskinidou; Alice G Vassiliou; Ioanna Dimopoulou; Anastasia Kotanidou; Stylianos E Orfanos
Journal:  J Inflamm Res       Date:  2022-06-15

Review 4.  Sepsis biomarkers: a review.

Authors:  Charalampos Pierrakos; Jean-Louis Vincent
Journal:  Crit Care       Date:  2010-02-09       Impact factor: 9.097

5.  Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films, II: albumin-inhibited pulmonary surfactant films and the effect of SP-A.

Authors:  Yi Y Zuo; Seyed M Tadayyon; Eleonora Keating; Lin Zhao; Ruud A W Veldhuizen; Nils O Petersen; Matthias W Amrein; Fred Possmayer
Journal:  Biophys J       Date:  2008-06-06       Impact factor: 4.033

6.  Pulmonary surfactant surface tension influences alveolar capillary shape and oxygenation.

Authors:  Machiko Ikegami; Timothy E Weaver; Shawn N Grant; Jeffrey A Whitsett
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-06       Impact factor: 6.914

7.  Surfactant-associated protein A is important for maintaining surfactant large-aggregate forms during surface-area cycling.

Authors:  R A Veldhuizen; L J Yao; S A Hearn; F Possmayer; J F Lewis
Journal:  Biochem J       Date:  1996-02-01       Impact factor: 3.857

Review 8.  Surfactant alteration and replacement in acute respiratory distress syndrome.

Authors:  A Günther; C Ruppert; R Schmidt; P Markart; F Grimminger; D Walmrath; W Seeger
Journal:  Respir Res       Date:  2001-10-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.